Home/Filings/4/0001062993-23-022642
4//SEC Filing

Amron Arthur H 4

Accession 0001062993-23-022642

CIK 0001196298other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:47 PM ET

Size

5.0 KB

Accession

0001062993-23-022642

Insider Transaction Report

Form 4
Period: 2023-12-13
Transactions
  • Award

    Common Stock

    2023-12-13+9,2919,291 total
Footnotes (1)
  • [F1]On December 13, 2023, the Company granted 9,291 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company for 2023. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001179697

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:47 PM ET
Size
5.0 KB